Correlation Between NurExone Biologic and Firan Technology
Can any of the company-specific risk be diversified away by investing in both NurExone Biologic and Firan Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NurExone Biologic and Firan Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NurExone Biologic and Firan Technology Group, you can compare the effects of market volatilities on NurExone Biologic and Firan Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NurExone Biologic with a short position of Firan Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of NurExone Biologic and Firan Technology.
Diversification Opportunities for NurExone Biologic and Firan Technology
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between NurExone and Firan is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding NurExone Biologic and Firan Technology Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Firan Technology and NurExone Biologic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NurExone Biologic are associated (or correlated) with Firan Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Firan Technology has no effect on the direction of NurExone Biologic i.e., NurExone Biologic and Firan Technology go up and down completely randomly.
Pair Corralation between NurExone Biologic and Firan Technology
Assuming the 90 days horizon NurExone Biologic is expected to generate 62.3 times less return on investment than Firan Technology. In addition to that, NurExone Biologic is 3.01 times more volatile than Firan Technology Group. It trades about 0.0 of its total potential returns per unit of risk. Firan Technology Group is currently generating about 0.06 per unit of volatility. If you would invest 590.00 in Firan Technology Group on December 2, 2024 and sell it today you would earn a total of 177.00 from holding Firan Technology Group or generate 30.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NurExone Biologic vs. Firan Technology Group
Performance |
| Timeline |
| NurExone Biologic |
| Firan Technology |
NurExone Biologic and Firan Technology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NurExone Biologic and Firan Technology
The main advantage of trading using opposite NurExone Biologic and Firan Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NurExone Biologic position performs unexpectedly, Firan Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Firan Technology will offset losses from the drop in Firan Technology's long position.| NurExone Biologic vs. Medical Facilities | NurExone Biologic vs. Quipt Home Medical | NurExone Biologic vs. Mayfair Acquisition | NurExone Biologic vs. Champion Iron |
| Firan Technology vs. Hammond Power Solutions | Firan Technology vs. Questor Technology | Firan Technology vs. Vecima Networks | Firan Technology vs. Magellan Aerospace |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |